Department of Cellular Pathology, UCL Medical School, Royal Free Campus, London, UK.
Histopathology. 2013 Feb;62(3):421-30. doi: 10.1111/his.12010. Epub 2012 Nov 8.
The requirements for adequate cirrhotic liver biopsy size have not been established for quantitative fibrosis measurements (collagen proportionate area: CPA). We evaluated the CPA of virtual biopsies in cirrhosis to elucidate (i) the amount of tissue required to achieve reliable CPA measurements and (ii) the effect of aetiology on sample size requirements.
A total of 120 cirrhotic tissue blocks (six aetiologies) were studied. A representative 100 mm(2) region was selected from each block and a reference CPA measured. Each image (n = 120) was divided into 100 × 1 mm(2) images; CPA was measured for each 1 mm(2) and virtual biopsies of different sizes were created from the 1 mm(2) components. For each virtual biopsy size the probability that the virtual biopsy CPA would be within 5% of the reference CPA was calculated. There were 441 000 virtual biopsies. Biopsy size versus probability plots indicated that, for 90% probability that the virtual biopsy CPA can be expected to be within 5% of the reference CPA, 22-28 mm(2) of analysable tissue is required depending on liver disease aetiology; and that a 75% probability level requires a biopsy with 12-15 mm(2) of analysable tissue.
The sample size required for a given probability level depends on the aetiology of cirrhosis, and this should be taken into account when judging the reliability of cirrhotic liver biopsy CPA.
对于定量纤维化测量(胶原比例面积:CPA),尚未确定足够的肝硬化肝活检大小的要求。我们评估了肝硬化虚拟活检的 CPA,以阐明(i)获得可靠 CPA 测量所需的组织量,以及(ii)病因对样本量要求的影响。
共研究了 120 个肝硬化组织块(六种病因)。从每个块中选择一个有代表性的 100mm²区域,并测量参考 CPA。对每个图像(n=120)进行分割,将其分为 100×1mm²的图像;对每个 1mm²的图像进行 CPA 测量,并从 1mm²的组成部分创建不同大小的虚拟活检。对于每个虚拟活检的大小,计算虚拟活检 CPA 与参考 CPA 的差异在 5%以内的概率。总共创建了 441000 个虚拟活检。活检大小与概率图表明,对于 90%的概率,预计虚拟活检的 CPA 可以在参考 CPA 的 5%以内,需要 22-28mm²的可分析组织,这取决于肝脏疾病的病因;而 75%的概率水平需要具有 12-15mm²的可分析组织的活检。
给定概率水平所需的样本量取决于肝硬化的病因,在判断肝硬化肝活检 CPA 的可靠性时应考虑这一点。